An in vivo study into the metabolic reprogramming of hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Humboldt-Universität zu Berlin, Dissertation, 2017
- Schlagwort
-
Liver--Cancer
Metabolism
Mice
Liver
Cancer
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Humboldt-Universität zu Berlin
- (wann)
-
2018
- Urheber
- Beteiligte Personen und Organisationen
-
Landthaler, Markus
Sers, Christine
Cramer, Thorsten
- DOI
-
10.18452/19268
- URN
-
urn:nbn:de:kobv:11-110-18452/20030-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vvedenskaya, Olga
- Landthaler, Markus
- Sers, Christine
- Cramer, Thorsten
- Humboldt-Universität zu Berlin
Entstanden
- 2018
Ähnliche Objekte (12)
Targeting effectors of metabolic reprogramming in hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Computational Analysis of Metabolic Reprogramming in Tumors
Targeting effectors of metabolic reprogramming in hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Computational Analysis of Metabolic Reprogramming in Tumors
Targeting effectors of metabolic reprogramming in hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Progress in hepatocellular carcinoma treatment
Targeting FUBP1 in Hepatocellular Carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Influence of components of the metabolic syndrome on development and progression of hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients